Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202708 · ClinicalTrials.gov registry record · NA
Gambro AK200 ULTRA Hemodiafiltration Study
A NA study of Chronic Renal Failure, sponsored by Vantive Health.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT01202708 is a NA study of Chronic Renal Failure that has completed, run by Vantive Health. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01202708, a NA study of Chronic Renal Failure, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to assess the safety, efficacy and dialytic capabilities of hemodiafiltration with on-line prepared substitution fluid using the AK200 ULTRA in comparison to conventional hemodialysis.
Conditions Studied
Interventions
- DEVICE On line hemofiafiltration
- DEVICE On line hemodiafiltration
Study Locations (1)
District of Columbia
- George Washington University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 1997-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01202708
The ClinicalTrials.gov registry entry for NCT01202708 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Renal Failure appearing as the primary indexed condition, and to 2 interventions - of which On line hemofiafiltration is the first listed.
NCT01202708 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01202708 about?
NCT01202708 is a clinical study titled "Gambro AK200 ULTRA Hemodiafiltration Study". This study is designed to assess the safety, efficacy and dialytic capabilities of hemodiafiltration with on-line prepared substitution fluid using the AK200 ULTRA in comparison to conventional hemodialysis.
What is the current status of trial NCT01202708?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 1997-08.
What conditions does trial NCT01202708 study?
This clinical trial studies the following conditions: Chronic Renal Failure.
What interventions are being tested in trial NCT01202708?
The interventions under investigation include: On line hemofiafiltration (DEVICE), On line hemodiafiltration (DEVICE).
Who is sponsoring clinical trial NCT01202708?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01202708 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Renal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.